Informace o publikaci

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.

Autoři

SALAJ Peter BRABEC Petr PENKA Miroslav POHLREICHOVÁ V. SMEJKAL Petr CETKOVSKÝ Petr DUŠEK Ladislav HEDNER U.

Rok publikování 2009
Druh Článek v odborném periodiku
Časopis / Zdroj Haemophilia
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Obor Onkologie a hematologie
Klíčová slova bleeding; dose; haemophilia; inhibitors; registry; rFVIIa
Popis Identifying haemophilia patients with inhibitors for clinical trials is difficult due to the limited number of patients available. Registries are therefore being established as an additional means of data collection. The aim of this study was to investigate the effect of different recombinant activated factor VII (rFVIIa; NovoSeven((R))) dose ranges and dosing schedules on the incidence of re-bleeding in haemophilia patients with inhibitors. In this retrospective, uncontrolled study, data on the bleeding patterns of adult haemophilia patients with high responding inhibitors were analysed.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info